A comparison of some cardiovascular properties of propranolol, MJ 1999 and quinidine in relation to their effects in hypertensive animals
- PMID: 5676002
- PMCID: PMC1703443
- DOI: 10.1111/j.1476-5381.1968.tb07955.x
A comparison of some cardiovascular properties of propranolol, MJ 1999 and quinidine in relation to their effects in hypertensive animals
Abstract
1. A comparison of some cardiovascular effects of propranolol, MJ 1999 and quinidine has been made in rats and dogs.2. After intravenous, subcutaneous or oral administration to rats and dogs, propranolol was found to be 2-4 times more potent than MJ 1999 in blocking the chronotropic and vasodepressor responses to intravenously administered isoprenaline.3. Propranolol and quinidine affected the e.c.g. of rats and dogs in a similar manner.4. At dose-levels causing effective blockade of beta-receptors propranolol and MJ 1999 had no hypotensive effect after short- or long-term administration to conscious hypertensive rats and dogs.5. At very high dose-levels propranolol and quinidine, but not MJ 1999, lowered blood pressure in the hypertensive rat. This effect of propranolol is probably related to one or more of the properties that propranolol and quinidine have in common rather than to a blockade of beta-receptors.6. The possible relevance of these results to the use of propranolol as a hypotensive agent in man is discussed.
Similar articles
-
Comparison of the effects of propranolol and MJ 1999 on cardiac beta-adrenoceptors in man.Br J Pharmacol. 1970 May;38(3):546-53. doi: 10.1111/j.1476-5381.1970.tb10596.x. Br J Pharmacol. 1970. PMID: 4392540 Free PMC article. Clinical Trial.
-
A comparative study of some cardiovascular effects of sotalol (MJ 1999) and propranolol.Life Sci. 1969 Apr 1;8(7):353-65. doi: 10.1016/0024-3205(69)90228-8. Life Sci. 1969. PMID: 5769443 No abstract available.
-
Adrenergic blocking properties of MJ 1999 and butoxamine on cardiac and vascular beta-receptors.Arch Int Pharmacodyn Ther. 1968 Nov;176(1):218-32. Arch Int Pharmacodyn Ther. 1968. PMID: 5709786 No abstract available.
-
A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.Br J Clin Pharmacol. 1976 Aug;3(4 Suppl 3):681-4. Br J Clin Pharmacol. 1976. PMID: 10948 Review.
-
[Beta-receptor-blocking agents and their current clinical significance].Dtsch Gesundheitsw. 1968 Dec 12;23(50):2353-63. Dtsch Gesundheitsw. 1968. PMID: 4389656 Review. German. No abstract available.
Cited by
-
Intragastric capsaicin enhances rat gastric acid elimination and mucosal blood flow by afferent nerve stimulation.Br J Pharmacol. 1989 Jan;96(1):91-100. doi: 10.1111/j.1476-5381.1989.tb11788.x. Br J Pharmacol. 1989. PMID: 2924079 Free PMC article.
-
Prevention and reversal of isolation-induced systolic arterial hypertension in rats by treatment with beta-adrenoceptor antagonists.Br J Pharmacol. 1979 Feb;65(2):205-13. doi: 10.1111/j.1476-5381.1979.tb07820.x. Br J Pharmacol. 1979. PMID: 32946 Free PMC article.
-
Treatment of hypertension with a new beta-blocking agent, pindolol (Visken).Eur J Clin Pharmacol. 1973 Dec;6(4):217-9. doi: 10.1007/BF00644734. Eur J Clin Pharmacol. 1973. PMID: 4591149 Clinical Trial. No abstract available.
-
The mechanism of the augmentation of the pressor response to angiotensinamide and to adrenaline by beta-adrenoceptor blocking agents in the rat.Naunyn Schmiedebergs Arch Pharmacol. 1977 Nov;300(2):107-13. doi: 10.1007/BF00505040. Naunyn Schmiedebergs Arch Pharmacol. 1977. PMID: 593432 No abstract available.
-
Beta-Adrenoceptor studies. 4. Influence of albumin on in vitro beta-adrenoceptor blocking and antiarrhythmic properties of propranolol, pindolol, practolol and metoprolol.Naunyn Schmiedebergs Arch Pharmacol. 1977 May;298(1):29-36. doi: 10.1007/BF00510983. Naunyn Schmiedebergs Arch Pharmacol. 1977. PMID: 18685 No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources